Clinical Study on the Use of Omalizumab for IgE-Mediated Allergic Diseases.

The combined use of omalizumab with conventional anti-allergy treatment was effective in treating IgE-mediated seasonal allergic rhinitis, urticaria, and allergic asthma, providing a new therapeutic option for the clinical management of IgE-mediated allergic diseases.

Authors

Shuang Ren
Yufei Dong
Xiaochao Gao
Yan Wang (ORCID: https://orcid.org/0000-0001-6111-5379)

Publication Details

Journal: PubMed
Published: 2025-09-01
Citations: 1
Primary Topic: Urticaria and Related Conditions
Type: article
Field-Weighted Citation Impact: 1.67

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Clinical Study on the Use of Omalizumab for IgE-Mediated Allergic Diseases.

Shuang Ren, Yufei Dong, Xiaochao Gao, Yan Wang

Sep 1, 2025

1 citations

PubMed

Urticaria and Related Conditions

1.67

article

Clinical Study on the Use of Omalizumab for IgE-Mediated Allergic Diseases.

Shuang Ren, Yufei Dong, Xiaochao Gao, Yan Wang

September 1, 2025article en

1 citations

Abstract

PubMedVol. 31(5)

Good health and well-being

Openalex Percentile: Top 22%

Urticaria and Related Conditions

1.67

OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Clinical Study on the Use of Omalizumab for IgE-Mediated Allergic Diseases. — Shuang Ren, Yufei Dong, et al. · PubMed (2025) | TGRS Research Map | TGRS